Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine + Carboplatin/Gemcitabine in Advanced Solid Tumors
NCT02071537Phase 1Completed
- Sponsor
- University of Cincinnati
- Start
- May 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of chloroquine in solid tumor, sponsored by University of Cincinnati. Primary endpoint: Maximum Tolerated Dose at 12 months. Started May 2014; status: completed.
02
Drugs
chloroquine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02071537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071537.